GSK Plc (GSK)
49.02
+1.15
(+2.40%)
USD |
NYSE |
Oct 15, 16:00
49.40
+0.38
(+0.78%)
Pre-Market: 09:02
GSK SG&A Expense (TTM) : 12.34B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.34B |
| March 31, 2026 | 12.24B |
| December 31, 2025 | 11.99B |
| September 30, 2025 | 11.90B |
| June 30, 2025 | 13.82B |
| March 31, 2025 | 14.07B |
| December 31, 2024 | 14.11B |
| September 30, 2024 | 14.02B |
| June 30, 2024 | 11.98B |
| March 31, 2024 | 11.71B |
| December 31, 2023 | 11.67B |
| September 30, 2023 | 11.21B |
| June 30, 2023 | 10.72B |
| March 31, 2023 | 10.47B |
| December 31, 2022 | 11.68B |
| September 30, 2022 | 11.78B |
| June 30, 2022 | 11.67B |
| March 31, 2022 | 11.45B |
| December 31, 2021 | 10.98B |
| September 30, 2021 | 12.20B |
| June 30, 2021 | 13.33B |
| March 31, 2021 | 14.33B |
| December 31, 2020 | 14.71B |
| September 30, 2020 | 14.97B |
| June 30, 2020 | 15.08B |
| Date | Value |
|---|---|
| March 31, 2020 | 15.05B |
| December 31, 2019 | 14.55B |
| September 30, 2019 | 13.49B |
| June 30, 2019 | 13.22B |
| March 31, 2019 | 13.23B |
| December 31, 2018 | 13.22B |
| September 30, 2018 | 13.21B |
| June 30, 2018 | 12.94B |
| March 31, 2018 | 12.64B |
| December 31, 2017 | 12.46B |
| September 30, 2017 | 12.45B |
| June 30, 2017 | 12.44B |
| March 31, 2017 | 12.48B |
| December 31, 2016 | 12.54B |
| September 30, 2016 | 12.98B |
| June 30, 2016 | 13.00B |
| March 31, 2016 | 13.84B |
| December 31, 2015 | 14.10B |
| September 30, 2015 | 13.81B |
| June 30, 2015 | 14.12B |
| March 31, 2015 | 13.67B |
| December 31, 2014 | 13.58B |
| September 30, 2014 | 12.64B |
| June 30, 2014 | 12.38B |
| March 31, 2014 | 12.31B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| AstraZeneca PLC | 585.31M |
| Johnson & Johnson | 19.22B |
| Eli Lilly & Co. | 12.24B |
| Merck & Co., Inc. | 11.14B |
| Novo Nordisk A/S | 10.12B |